Sizing the cannabis market: A demand-side and user-specific approach in Seven European Countries

Current Drug Abuse Reviews

Volumn 6, Issue 2, 2013, Pages 152-164

  Van Laar, Margriet ^a   Frijns, Tom ^a   Trautmann, Franz ^a   Lombi, Linda ^b  

^a NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cannabis; Consumption estimates; Demand; Drugs market

Indexed keywords

3, 4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CANNABIS; COCAINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTICLE; BULGARIA; CZECH REPUBLIC; DRUG ABUSE; DRUG MARKETING; EUROPE; FEMALE; FOLLOW UP; GENDER; HEALTH CARE NEED; HEALTH SURVEY; HUMAN; INTERNET; ITALY; MALE; MIDDLE AGED; NETHERLANDS; POPULATION RESEARCH; PORTUGAL; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING; SWEDEN; TOBACCO; UNITED KINGDOM; YOUNG ADULT; CANNABIS SMOKING; EPIDEMIOLOGY; INFORMATION PROCESSING; MARIJUANA ABUSE; TIME;

ADOLESCENT; ADULT; DATA COLLECTION; EUROPE; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; TIME FACTORS; YOUNG ADULT;

EID: 84899444056     PISSN: 18744737     EISSN: 18744745     Source Type: Journal    
DOI: 10.2174/1874473706666131205152835     Document Type: Article

References (40)

1. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Annual report 2012: the state of the drugs problem in Europe. Lisbon: EMCDDA, 2012.
2. Kilmer B, Caulkins J, Pacula R, Reuter P. Bringing perspective to illicit markets: estimating the size of the U.S. marijuana market. Drug Alcohol Depend 2011; 119(1-2): 153-160.
3. Werb D, Nosyk B, Kerr T, Fischer B, Montaner J, Wood E. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy. Int J Drug Policy 2012; 23(6): 436-441.
4. Hakkarainen P, Kainulainen H, Perälä J. Measuring the cannabis market in Finland: A consumption-based estimate. Contemporary Drug Problems: An Interdisciplinary Quarterly 2008; 35(2-3): 321-345.
5. Reuter P, Trautmann F. A report on global illicit drugs markets 1998-2007: full report. Brussel: European Communities, 2009.
6. Kilmer B, Pacula R. Estimating the size of the global drug market: a demand-side approach. In: Reuter P, Trautmann F, editors. A Report on Global Illicit Drugs Markets 1998-2007: full report. Brussels: European Communities, 2009: 99-156.
7. Wilkins C, Reilly JL, Pledger M, Casswell S. Estimating the dollar value of the illicit market for cannabis in New Zealand. Drug Alcohol Rev 2005; 24(3): 227-234.
8. Fischer B, Rehm J, Irving H, Ialomiteanu A, Fallu JS, Patra J. Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. Int J Methods Psychiatr Res 2010; 19(2): 110-124.
9. Hammersley R, Leon V. Patterns of cannabis use and positive and negative experiences of use amongst university students. Addiction Research & Theory 2006; 14(2): 189-205.
10. Korf DJ, Benschop A, Wouters M. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour. Int J Drug Policy 2007; 18(3): 168-176.
11. Miller P, Plant M. Heavy cannabis use among UK teenagers: an exploration. Drug Alcohol Depend 2002; 65(3): 235-242.
12. Senate Special Committee on Illigal Drugs (Senate). Cannabis: our position for a public policy. Ottawa: Senate of Canada, 2002.
13. United Nations Office On Drugs and Crime (UNODC). World Drug Report: 2009. Vienna: UNODC, 2009.
14. Temple EC, Brown RF, Hine DW. The 'grass ceiling': limitations in the literature hinder our understanding of cannabis use and its consequences. Addiction 2011; 106(2): 238-244.
15. Van der Pol P, Liebregts N, De Graaf R, Korf D, Van den Brink W, Van Laar M. Validation of self-reported cannabis dose and potency: an ecological study. Addiction [Epub ahead of print] 2013.
16. Wittchen HU, Behrendt S, Hofler M, et al. A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs. Drug Alcohol Depend 2009; 102(1-3): 151-157.
17. Zeisser C, Thompson K, Stockwell T, et al. A 'standard joint'? The role of quantity in predicting cannabis-related problems. Addict Res Theory 2012; 20(1): 82-92.
18. Observatoire Français des Drogues et des Toxicomanies (OFDT). Drugs and drug addictions - indicators and trends 2002: Cannabis. Paris: OFDT, 2002.
19. Pudney S, Badillo C, Bryan M, Burton J, Conti G, Iacovou M. Estimating the size of the UK illicit drug market. In: Singleton N, Murray R, Tinsley L, Eds. Measuring different aspects of problem drug use: methodological developments. London: Home Office, 2006: 46-88.
20. Trautmann F, Kilmer B, Turnbull P. Further insights into aspects of the illicit EU drugs market. Luxembourg: Publications Office of the European Union, 2013.
21. Van Laar M, Frijns T, Trautmann F, Lombi L. Cannabis market: User types, availability and consumption estimates. In: Trautmann F, Kilmer B, Turnbull P, editors. Further insights into aspects of the EU illicit drugs market. Luxembourg: Publications Office of the European Union, 2013: 73-182.
22. Van Laar M, Trautmann F, Frijns T. Drugs market: an assessment from the demand side: introduction. In: Trautmann F, Kilmer B, Turnbull P, editors. Further insights into aspects of the EU illicit drugs market. Luxembourg: Publications Office of the European Union, 2013: 57-72.
23. Eurostat. Population and social conditions: demography: national data: population by sex and age on 1. January of each year. Luxembourg: Eurostat, 2012.
24. Shiffman S, Kassel JD, Paty J, Gnys M, Zettler-Segal M. Smoking typology profiles of chippers and regular smokers. J Subst Abuse 1994; 6(1): 21-35.
25. Carpentier C, Mulligan K, Laniel L, Potter D, Hughes B, Vandam L et al. Cannabis production and markets in Europe. Lisbon: EMCDDA, 2012.
26. Santoro M, Triolo L, Rossi C. Drug users dynamics: a compartmental model of drug users to make scenario analyses. Rome: University of Rome, 2011.
27. Fabi F, Mammone A, Ricci R, Rossi C. Monitoring and assessing drug policies: indicators of drug use in the teenage population as a tool for cross country comparisons. Rome: Illicit Drug Market Institute, 2011.
28. Bauermeister JA, Zimmerman MA, Johns MM, Glowacki P, Stoddard S, Volz E. Innovative recruitment using online networks: lessons learned from an online study of alcohol and other drug use utilizing a web-based, Respondent-Driven Sampling (webRDS) strategy. J Stud Alcohol Drugs 2012; 73(5): 834-838.
29. Carhart-Harris RL, Nutt DJ, Munafo M, Wilson SJ. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J Psychopharmacol 2009; 23(3): 249-257.
30. Miller PG, Sonderlund AL. Using the internet to research hidden populations of illicit drug users: a review. Addiction 2010; 105(9): 1557-1567.
31. Stein LA, Lebeau R, Clair M, Martin R, Bryant M, Storti S. Preliminary web-based measures development for GHB: expectancies, functions, and withdrawal. Am J Drug Alcohol Abuse 2012; 38(2): 121-129.
32. Walden N, Earleywine M. How high: quantity as a predictor of cannabis-related problems. Harm Reduct J 2008; 5: 20.
33. Harrison LD, Martin SS, Enev T, Harrington D. Comparing drug testing and self-report of drug use among youths and young adults in the general population. Rockville: Department of Health and Human Services, 2007.
34. Magura S. Validating self-reports of illegal drug use to evaluate National Drug Control Policy: a reanalysis and critique. Eval Program Plann 2010; 33(3): 234-237.
35. Fendrich M, Johnson TP, Wislar JS, Hubbell A, Spiehler V. The utility of drug testing in epidemiological research: results from a general population survey. Addiction 2004; 99(2): 197-208.
36. Taylor B, Bennett T. Comparing Drug Use Rates of Detained Arrestees in the United States and England. Washington: National Institute of Justice, 1999.
37. Bouchard M, Tremblay P. Risks of arrest across drug markets: A capture-recapture analysis of 'hidden' dealer and user populations. Journal of Drug Issues 2005; 35(4): 733-754.
38. Caulkins JP, Kilmer B. Estimating the size of the EU cannabis market. In: Trautmann F, Kilmer B, Turnbull P, editors. Further insights into aspects of the EU illicit drugs market. Luxembourg: Publications Office of the European Union, 2013: 289-322.
39. Jansen F. Georganiseerde hennepteelt: criminaliteitsbeeldanalyse 2012. Driebergen: KLPD-Dienst Nationale Recherche, 2012.
40. Eisenbach-Stangl I, Moskalewicz J, Thom B. Two Worlds of Drug Consumption in Late Modern Societies. Policy Brief January (1). European Centre, 2010.